Session Description:
Hear from the experts about the pathophysiology of CKD-MBD from childhood to the elderly and applying this knowledge in everyday clinical practice. Gain a balanced view of mineral bone disease in CKD, by reviewing a European consensus report and the recent KDIGO controversies conference. Get an update on the challenges and opportunities of existing and emerging bone biomarkers for the evaluation of bone disease in CKD.
Learning Objectives:
Understanding CKD-MBD management to optimise treatment. Interpreting bone biomarkers
| Time | Session |
|---|
|
9:45 a.m.
10:03 a.m.
|
What Should a Clinician Know About CKD-MBD in 2025?
|
|
10:03 a.m.
10:21 a.m.
|
CKD-MBD in Children and Young Adults: What's the Difference?
|
|
10:21 a.m.
10:39 a.m.
|
Progress in CKD-driven Vascular Calcification: From Bench to Bedside
|
|
10:39 a.m.
10:57 a.m.
|
How to Use Serum Biomarkers for Optimal Management of CKD-MBD
|
|
10:57 a.m.
11:15 a.m.
|
Q&A
|